Category: Prostate Cancer
“Power to the people!” This slogan, and variations of it, took on a life of its own in the Sixties and Seventies. John Lennon even wrote a song with that title, and James Brown used it as a lyric. Change that comes as a result of a social movement is often referred to as change keep reading
I can’t begin to count the number of times patients have asked me questions like these: “Why isn’t focal laser ablation covered by Medicare or insurance?” “My urologist said he won’t do my follow-up if I have focal laser ablation. Do you know a laser-friendly urologist in my area who will work with me?” “How keep reading
On November 18, 2015 the New York Times carried an article titled “Early Prostate Cancer Cases Fall Along With Screening.” Ever since the U.S. Preventive Services Task Force recommended against broad PSA screening on the grounds that it leads to overdetection and overtreatment, two opposing positions have been created. One position favors the recommendation on keep reading
Roughly 14% of American men will be diagnosed with prostate cancer (PCa) in their lifetime. It is the second leading cause of death in men, after lung cancer—yet it is a highly curable disease if caught early, and if choice of treatment matches the disease. This year, over 220,000 new cases will be diagnosed. Today, keep reading
Mark Moyad, MD, professor of preventive and alternative medicine at the University of Michigan, is renowned for his extensive knowledge on how nutrition, supplements and exercise protect against prostate cancer. He recently published a detailed report, “Preventing Aggressive Prostate Cancer with Proven Cardiovascular Disease Preventive Methods.”[i] He lists risk factors for cardiovascular disease (CVD) that keep reading
How do you prepare for a prostate cancer consultation? While I can’t speak for everyone in my profession, I believe these days most urologists and radiologists are comfortable with patients bringing in a list of questions. I encourage patients to do so, especially if they are facing a detection, diagnosis, or decision-making process regarding prostate keep reading
Thanks to new evidence that testosterone replacement therapy (TRT) does not increase prostate cancer risk, many PCa patients with low testosterone are breathing sighs of relief. Testosterone levels tend to decrease as men age, by about 1% per year after age 30. Low testosterone – also called low T or hypogonadism – affects approximately 13 keep reading
I have written past blogs about physical factors that increase the risk of dying from prostate cancer: genetic history, exposure to toxic agents, alcohol abuse, smoking, too much red meat, precursor conditions such as high grade PIN and ASAP, etc. However, there’s another risk factor that does not occur within the body, but certainly affects keep reading
You’ve probably heard the saying that a camel is a horse that was designed by a committee. It is a comic way of recognizing that groups of people with no unifying vision or systematic communication process are likely to fail at collective design. However, there is an effective antidote. It is an approach to gaining keep reading
We live in an age of medical specialties that “compete” for patients. In women’s health, for example, treating noncancerous growths called uterine fibroid tumors has traditionally been the territory of gynecologists. Gynecologists, like urologists, were trained in surgery so they often recommend hysterectomy (surgical removal of the uterus) as the gold standard for treating severe keep reading
